Moberg Pharma AB (publ) (MOB) — Cash Flow Reinvestment Rate
Moberg Pharma AB (publ) (MOB) has a Cash Flow Reinvestment Rate of 1.00x as of December 2025, reinvesting Skr1.52 Million (capex Skr1.52 Million ) from operating cash flow of Skr1.52 Million. Check MOB cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Moberg Pharma AB (publ) Cash Flow Reinvestment Rate (2012–2019)
Historical reinvestment intensity for Moberg Pharma AB (publ) across 6 annual periods. Explore MOB long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Moberg Pharma AB (publ) (2012–2019)
Year-by-year capital reinvestment analysis for Moberg Pharma AB (publ). For live market cap and broader valuation context, see market value of Moberg Pharma AB (publ).
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.73x | Skr2.87 Million | Skr3.95 Million | Skr2.87 Million | ▼ -67.9% |
| 2018 | 2.26x | Skr167.28 Million | Skr73.89 Million | Skr83.64 Million | ▲ +209.6% |
| 2017 | 0.73x | Skr39.35 Million | Skr53.82 Million | Skr19.68 Million | ▼ -48.8% |
| 2015 | 1.43x | Skr43.88 Million | Skr30.72 Million | Skr43.88 Million | ▲ +217.5% |
| 2014 | 0.45x | Skr7.27 Million | Skr16.16 Million | Skr7.27 Million | ▲ +576.8% |
| 2012 | 0.07x | Skr630.00K | Skr9.48 Million | Skr630.00K | — |